Cash Flow Statement
Growth Metrics

Elevance Health (ELV) Depreciation & Amortization (CF) (2016 - 2025)

Elevance Health (ELV) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $406.0 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 2.01% to $406.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 billion through Dec 2025, up 10.98% year-over-year, with the annual reading at $1.5 billion for FY2025, 10.98% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $406.0 million at Elevance Health, up from $387.0 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $473.0 million in Q4 2022, with the low at $282.0 million in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $383.0 million, with a median of $383.5 million recorded in 2025.
  • The sharpest move saw Depreciation & Amortization (CF) soared 31.39% in 2022, then decreased 28.35% in 2024.
  • Over 5 years, Depreciation & Amortization (CF) stood at $360.0 million in 2021, then skyrocketed by 31.39% to $473.0 million in 2022, then decreased by 10.36% to $424.0 million in 2023, then dropped by 6.13% to $398.0 million in 2024, then rose by 2.01% to $406.0 million in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $406.0 million, $387.0 million, and $380.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.